{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T23:00:53Z","timestamp":1788217253202,"version":"build-2803163510"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Using a multicenter clinical data, this study aimed to systematically analyze the clinical characteristics, pathogen spectrum, and independent risk\/protective factors for coinfection in SFTS patients; additionally, it sought to explore optimal therapeutic regimens to reduce the case fatality rate of SFTS patients with coinfection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Clinical data of 1,675 patients with SFTS who were hospitalized for the first time, collected from 6 institutions between May 2011 and November 2024, were included and analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The coinfection group had a significantly higher case fatality rate (24.3% vs. 6.7%,\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001), with the mixed bacterial-fungal infection subgroup showing the highest mortality risk (Log-rank test,\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001). Albumin served as a protective factor against coinfection, with a cutoff value of 32 g\/L identified; administering human albumin at this threshold could partially reduce the coinfection rate. Furthermore, on the basis of this protective effect of albumin, the combination of human albumin and corticosteroids was associated with a trend toward improved prognostic survival in coinfected patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study found a high proportion of SFTS patients with coinfection, which significantly worsens their clinical prognosis. SFTS currently has no specific therapy; clinical treatment focuses on symptomatic and supportive care, with strict standardization for antibiotics and antifungal use, and attention to patients\u2019 nutritional support. Albumin is a key protective factor associated with a lower risk of coinfection in SFTS patients; combined use of human albumin and corticosteroids was associated with a further trend toward better clinical prognosis in coinfected patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcimb.2025.1708979","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T06:31:41Z","timestamp":1763706701000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Pathogen spectrum, clinical traits and exploration of mortality outcome-improving medication regimens in coinfection patients with severe fever with thrombocytopenia syndrome: a multicenter cohort study"],"prefix":"10.3389","volume":"15","author":[{"given":"Zibo","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianhe","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanyun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanni","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7563820","DOI":"10.1155\/2018\/7563820","article-title":"Synthesis, characterization, and BSA-binding studies of novel sulfonated zinc-triazine complexes","volume":"2018","author":"Abeydeera","year":"2018","journal-title":"Bioinorganic Chem. Appl."},{"key":"B2","doi-asserted-by":"publisher","first-page":"pgac024","DOI":"10.1093\/pnasnexus\/pgac024","article-title":"Exploration of immunological responses underpinning severe fever with thrombocytopenia syndrome virus infection reveals IL-6 as a therapeutic target in an immunocompromised mouse model","volume":"1","author":"Bryden","year":"2022","journal-title":"PNAS nexus"},{"key":"B3","first-page":"37","article-title":"Low serum albumin and the increased risk of amikacin nephrotoxicity","volume":"46","author":"Contreras","year":"1994","journal-title":"Rev. investigacion clinica"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"New Engl. J. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/17512433.2018.1412827","article-title":"Non-oncotic properties of albumin. A multidisciplinary vision about the implications for critically ill patients","volume":"11","author":"Ferrer","year":"2018","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/j.1365-2125.2011.04005.x","article-title":"Population pharmacokinetics of ceftriaxone in critically ill septic patients: a reappraisal","volume":"72","author":"Garot","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"5933","DOI":"10.1002\/jmv.28093","article-title":"Coinfections in hospitalized patients with severe fever with thrombocytopenia syndrome: A retrospective study","volume":"94","author":"Ge","year":"2022","journal-title":"J. Med. Virol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"16045","DOI":"10.1038\/nrdp.2016.45","article-title":"Sepsis and septic shock","volume":"2","author":"Hotchkiss","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1128\/AAC.02026-15","article-title":"Albumin enhances caspofungin activity against aspergillus species by facilitating drug delivery to germinating hyphae","volume":"60","author":"Ioannou","year":"2015","journal-title":"Antimicrobial Agents chemotherapy"},{"key":"B11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.clim.2018.07.009","article-title":"CD4 T cell loss and Th2 and Th17 bias are associated with the severity of severe fever with thrombocytopenia syndrome (SFTS)","volume":"195","author":"Li","year":"2018","journal-title":"Clin. Immunol. (Orlando Fla.)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.3201\/eid2211.161021","article-title":"Severe fever with thrombocytopenia syndrome complicated by co-infection with spotted fever group Rickettsiae, China","volume":"22","author":"Lu","year":"2016","journal-title":"Emerging Infect. Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ijid.2013.08.011","article-title":"Plasma exchange and ribavirin for rapidly progressive severe fever with thrombocytopenia syndrome","volume":"18","author":"Oh","year":"2014","journal-title":"Int. J. Infect. diseases: IJID"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2520343","DOI":"10.1080\/21505594.2025.2520343","article-title":"Bandavirus dabieense: A review of epidemiology, clinical characteristics, pathophysiology, treatment and prevention","volume":"16","author":"Peng","year":"2025","journal-title":"Virulence"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.3855\/jidc.19032","article-title":"Can antiviral drugs address the treatment challenges of severe fever with thrombocytopenia syndrome? - a systematic meta-analysis","volume":"18","author":"Shen","year":"2024","journal-title":"J. infection developing countries"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.1038\/s41467-018-05746-9","article-title":"Deficient humoral responses and disrupted B-cell immunity are associated with fatal SFTSV infection","volume":"9","author":"Song","year":"2018","journal-title":"Nat. Commun."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1093\/infdis\/jis452","article-title":"Host cytokine storm is associated with disease severity of severe fever with thrombocytopenia syndrome","volume":"206","author":"Sun","year":"2012","journal-title":"J. Infect. Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1172\/JCI129171","article-title":"Severe fever with thrombocytopenia syndrome virus targets B cells in lethal human infections","volume":"130","author":"Suzuki","year":"2020","journal-title":"J. Clin. Invest."},{"key":"B19","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1093\/infdis\/jit603","article-title":"The first identification and retrospective study of Severe Fever with Thrombocytopenia Syndrome in Japan","volume":"209","author":"Takahashi","year":"2014","journal-title":"J. Infect. Dis."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1448710","article-title":"Clinical factors associated with invasive pulmonary aspergillosis in patients with severe fever with thrombocytopenia syndrome: analysis of a 6-year clinical experience","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Microbiol."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.01282-24","article-title":"Two-transcript signature for differentiation and clinical outcomes in severe fever with thrombocytopenia syndrome (SFTS) patients: a double-blind, multicenter, validation study","volume":"63","author":"Xu","year":"2025","journal-title":"J. Clin. Microbiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"287","DOI":"10.4269\/ajtmh.18-0088","article-title":"Mixed infection with severe fever with thrombocytopenia syndrome virus and two genotypes of scrub typhus in a patient, South Korea, 2017","volume":"99","author":"Yoo","year":"2018","journal-title":"Am. J. Trop. Med. hygiene"},{"key":"B23","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1080\/22221751.2019.1599696","article-title":"Rickettsia typhi infection in severe fever with thrombocytopenia patients, China","volume":"8","author":"Zhang","year":"2019","journal-title":"Emerging Microbes infections"},{"key":"B24","doi-asserted-by":"publisher","first-page":"5916","DOI":"10.1002\/jmv.28059","article-title":"Associated microbiota and treatment of severe fever with thrombocytopenia syndrome complicated with infections","volume":"94","author":"Zhang","year":"2022","journal-title":"J. Med. Virol."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.70252","article-title":"Geriatric nutritional risk index plays important role in predicting in-hospital mortality in patients with severe fever with thrombocytopenia syndrome: A multi-center observational study","volume":"97","author":"Zhang","year":"2025","journal-title":"J. Med. Virol."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28712","article-title":"Pulmonary infection in patients with severe fever with thrombocytopenia syndrome: A multicentre observational study","volume":"95","author":"Zuo","year":"2023","journal-title":"J. Med. Virol."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1708979\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T06:31:42Z","timestamp":1763706702000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1708979\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":26,"alternative-id":["10.3389\/fcimb.2025.1708979"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2025.1708979","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"article-number":"1708979"}}